In our study, we hypothesized that AZM inhibits LOX and LOXL-2 expression partly through the TGF-β1/Smad and JNK/c-Jun signaling pathways, thereby attenuating the degree of PF. The gene discussed is LOX; the disease is pemphigus foliaceus.